TriNetX said it acquired Custodix, a provider of services for clinical trial design, patient feasibility and more. The financial details of the transaction were not released.
TriNetX said it acquired Custodix, a provider of services for clinical trial design, patient feasibility and more. The financial details of the transaction were not released.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: